223 related articles for article (PubMed ID: 35596146)
21. The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial.
Dickman R; Emmons S; Cui H; Sewell J; Hernández D; Esquivel RF; Fass R
Aliment Pharmacol Ther; 2005 Sep; 22(6):547-55. PubMed ID: 16167971
[TBL] [Abstract][Full Text] [Related]
22. Decreasing oesophageal acid exposure in patients with GERD: a comparison of rabeprazole and omeprazole.
Galmiche JP; Zerbib F; Ducrottè P; Fournet J; Rampal P; Avasthy N; Humphries TJ
Aliment Pharmacol Ther; 2001 Sep; 15(9):1343-50. PubMed ID: 11552904
[TBL] [Abstract][Full Text] [Related]
23. A randomized, double-blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years.
Thjodleifsson B; Rindi G; Fiocca R; Humphries TJ; Morocutti A; Miller N; Bardhan KD;
Aliment Pharmacol Ther; 2003 Feb; 17(3):343-51. PubMed ID: 12562446
[TBL] [Abstract][Full Text] [Related]
24. Effect of
Liu W; Lu NH; Zhou X; Li Y; Xie Y; Zheng L; Zhu W; Xiao Q; Yang N; Zuo K; Xu T; Zhang H
Contemp Clin Trials Commun; 2023 Apr; 32():101085. PubMed ID: 36865679
[TBL] [Abstract][Full Text] [Related]
25. TOPPITS: Trial Of Proton Pump Inhibitors in Throat Symptoms. Study protocol for a randomised controlled trial.
Watson G; O'Hara J; Carding P; Lecouturier J; Stocken D; Fouweather T; Wilson J
Trials; 2016 Apr; 17():175. PubMed ID: 27036555
[TBL] [Abstract][Full Text] [Related]
26. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.
Caro JJ; Salas M; Ward A
Clin Ther; 2001 Jul; 23(7):998-1017. PubMed ID: 11519776
[TBL] [Abstract][Full Text] [Related]
27. Sleep disturbances and refractory gastroesophageal reflux disease symptoms in patients receiving once-daily proton pump inhibitors and efficacy of twice-daily rabeprazole treatment.
Fujiwara Y; Habu Y; Ashida K; Kusano M; Higuchi K; Arakawa T
Digestion; 2013; 88(3):145-52. PubMed ID: 24008338
[TBL] [Abstract][Full Text] [Related]
28. A randomized, double-blind, comparative study of standard-dose rabeprazole and high-dose omeprazole in gastro-oesophageal reflux disease.
Holtmann G; Bytzer P; Metz M; Loeffler V; Blum AL
Aliment Pharmacol Ther; 2002 Mar; 16(3):479-85. PubMed ID: 11876701
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: randomized placebo-controlled trial.
Foocharoen C; Chunlertrith K; Mairiang P; Mahakkanukrauh A; Suwannaroj S; Namvijit S; Wantha O; Nanagara R
Rheumatology (Oxford); 2017 Feb; 56(2):214-222. PubMed ID: 27179107
[TBL] [Abstract][Full Text] [Related]
30. Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial.
Björnsson E; Abrahamsson H; Simrén M; Mattsson N; Jensen C; Agerforz P; Kilander A
Aliment Pharmacol Ther; 2006 Sep; 24(6):945-54. PubMed ID: 16948806
[TBL] [Abstract][Full Text] [Related]
31. Short-term and long-term effect of diaphragm biofeedback training in gastroesophageal reflux disease: an open-label, pilot, randomized trial.
Sun X; Shang W; Wang Z; Liu X; Fang X; Ke M
Dis Esophagus; 2016 Oct; 29(7):829-836. PubMed ID: 26227494
[TBL] [Abstract][Full Text] [Related]
32. Randomized clinical trial: a double-blind, placebo-controlled study to assess the clinical efficacy and safety of alginate-antacid (Gaviscon Double Action) chewable tablets in patients with gastro-oesophageal reflux disease.
Wilkinson J; Wade A; Thomas SJ; Jenner B; Hodgkinson V; Coyle C
Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):86-93. PubMed ID: 30272584
[TBL] [Abstract][Full Text] [Related]
33. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Sigterman KE; Bonis P; Lau J; Numans ME
Cochrane Database Syst Rev; 2010 Nov; (11):CD002095. PubMed ID: 21069670
[TBL] [Abstract][Full Text] [Related]
34. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
Sigterman KE; van Pinxteren B; Bonis PA; Lau J; Numans ME
Cochrane Database Syst Rev; 2013 May; 2013(5):CD002095. PubMed ID: 23728637
[TBL] [Abstract][Full Text] [Related]
35. Long-term prevention of erosive or ulcerative gastro-oesophageal reflux disease relapse with rabeprazole 10 or 20 mg vs. placebo: results of a 5-year study in the United States.
Caos A; Breiter J; Perdomo C; Barth J
Aliment Pharmacol Ther; 2005 Aug; 22(3):193-202. PubMed ID: 16091056
[TBL] [Abstract][Full Text] [Related]
36. Tonghua Liyan granules in the treatment of Laryngopharyngeal reflux disease with stagnation of phlegm and qi syndrome: a randomized, double-blind, placebo-controlled study.
Li Y; Zheng M; Wang Y; Xu G; He Y; Wu Y; Wang X; Liu Y; Jiang Y; Liu X; Meng Y; Yap Y; Zhu S; He C; Zhou B
Front Pharmacol; 2024; 15():1275740. PubMed ID: 38464723
[No Abstract] [Full Text] [Related]
37. Rabeprazole: a review of its use in acid-related gastrointestinal disorders.
Langtry HD; Markham A
Drugs; 1999 Oct; 58(4):725-42. PubMed ID: 10551440
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic Evaluation of
Gan L; Wang Y; Huang S; Zheng L; Feng Q; Liu H; Liu P; Zhang K; Chen T; Fang N
Nutrients; 2024 Jan; 16(3):. PubMed ID: 38337627
[TBL] [Abstract][Full Text] [Related]
39. Meta-analysis: the effects of placebo treatment on gastro-oesophageal reflux disease.
Cremonini F; Ziogas DC; Chang HY; Kokkotou E; Kelley JM; Conboy L; Kaptchuk TJ; Lembo AJ
Aliment Pharmacol Ther; 2010 Jul; 32(1):29-42. PubMed ID: 20353496
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
